Suchergebnisse - "Gelber, R D"

PubPharm (38)

1

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

enthalten in: The New England journal of medicine | 2014

von Pagani, O. | Regan, M. | Walley, B. | +132

CommentIn: N Engl J Med. 2014 Jul 10;371(2):175-6. - PMID 25006724

2

Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Oakman, C. | Francis, P. | Crown, J. | +18

3

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

enthalten in: The Lancet. Oncology | 2011

von Regan, M. | Neven, P. | Giobbie-Hurder, A. | +114

4

Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

enthalten in: Breast cancer research : BCR | 2011

von Regan, M. | Price, K. | Giobbie-Hurder, A. | +103

5

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

enthalten in: The New England journal of medicine | 2009

von BIG 1-98 Collaborative Group | Mouridsen, H. | Giobbie-Hurder, A. | +110

CommentIn: Expert Opin Pharmacother. 2010 Feb;11(3):489-92. - PMID 20053139

6

Design, conduct, and analyses of Breast International Group (BIG) 1-98 : a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

enthalten in: Clinical trials (London, England) | 2009

von Giobbie-Hurder, A. | Price, K. | Gelber, R. | +102

7

Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2008

von Untch, M. | Gelber, R. | Jackisch, C. | +26

8

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2008

von Ravaioli, A. | Monti, F. | Regan, M. | +112

9

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer : role of endocrine responsiveness of the tumor

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2005

von Colleoni, M. | Li, S. | Gelber, R. | +16

10

Systemic treatments for women with breast cancer : outcome with relation to screening for the disease

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2003

von Goldhirsch, A. | Colleoni, M. | Domenighetti, G. | +1